Latest News and Press Releases
Want to stay updated on the latest news?
-
SCHOFIELD, Wis., March 10, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) has made a commitment to reach out and connect with those that are in need of finding relief from migraine...
-
SCHOFIELD, Wis., Feb. 7, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) announced today that it has entered into an agreement with Double Pump, Inc. designed to enhance marketing...
-
SCHOFIELD, Wis., Jan. 3, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) announced today that the manuscript of the clinical study of LipiGesic™ M has been completed and has been...
-
SCHOFIELD, Wis., Oct. 26, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCBB:PMBS) announced today that it is building upon its recently launched print advertising campaign for its migraine...
-
SCHOFIELD, Wis., Sept. 28, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), has announced that it will host a shareholder conference call on Wednesday, Sept. 29, 2010, at 4:10 p.m. EDT (3:10...
-
SCHOFIELD, Wis., Sept. 14, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCBB:PMBS) announced today that it is launching a print advertising campaign for its migraine medication LipiGesic™...
-
SCHOFIELD, Wis., July 20, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCBB:PMBS) Chairman and CEO Russell Mitchell writes to shareholders as follows: To Our Shareholders: In recent months,...
-
SCHOFIELD, Wis., July 6, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), announced today that a clinical study of LipiGesic™ M has been completed. The study design was a double...
-
SCHOFIELD, Wis., June 21, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), announced today that it has entered into an agreement with Media4Equity and its parent company, NewsUSA, for a...
-
SCHOFIELD, Wis., June 1, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription...